SCHEMBL24137196

SCHEMBL24137196

CCC(C)(C)c1cnc(OC)c(NS(=O)(=O)c2cccc(C(=O)N=O)c2)c1

nearest known ligand 0.42

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ PIK3CG P48736 2/20 0.41
▸ SLC40A1 Q9NP59 1/20 0.41
▸ PIK3CA P42336 4/20 0.40
▸ PIK3CD O00329 1/20 0.40
▸ PIK3CB P42338 1/20 0.40
▸ MTOR P42345 3/20 0.39
▸ PTGES2 Q9H7Z7 3/20 0.39
▸ ACLY P53396 2/20 0.39
▸ POLB P06746 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ HTT P42858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24139842 0.90 ALDH1A1 (0.50) ALDH1A1MEN1KMT2APIK3CGSLC40A1
SCHEMBL24137459 0.85 SLC40A1 (0.45) ALDH1A1MEN1KMT2APIK3CGSLC40A1
SCHEMBL24139841 0.84 SLC40A1 (0.46) ALDH1A1MEN1KMT2APIK3CGSLC40A1
SCHEMBL24139956 0.82 PIK3CG (0.49) ALDH1A1MEN1KMT2APIK3CGSLC40A1
SCHEMBL13975457 0.79 ACLY (0.53) ALDH1A1MEN1KMT2APIK3CGSLC40A1
SCHEMBL13975453 0.79 SLC40A1 (0.55) ALDH1A1MEN1KMT2APIK3CGSLC40A1
SCHEMBL24139833 0.75 SLC40A1 (0.41) ALDH1A1MEN1KMT2ASLC40A1ACLY
SCHEMBL24139765 0.74 SLC40A1 (0.56) ALDH1A1MEN1KMT2APIK3CGSLC40A1
SCHEMBL13976112 0.74 SLC40A1 (0.58) ALDH1A1MEN1KMT2APIK3CGSLC40A1
SCHEMBL13975439 0.74 ACLY (0.55) ALDH1A1MEN1KMT2APIK3CGSLC40A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2710018-B1 MACROCYCLIC COMPOUNDS AS PROTEIN KINASE INHIBITORS FUNDACION CENTRO NAC DE INVESTIGACIONES ONCOLOGICAS CARLOS III (ES) 2021-12-29 — — EP disclosed
Send feedback